Mirtazapine and Simbrinza drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 7 people who take Mirtazapine and Simbrinza. Common interactions include blood magnesium decreased among females, and aphasia among males.
The phase IV clinical study analyzes what interactions people who take Mirtazapine and Simbrinza have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7 people who take Mirtazapine and Simbrinza together, and have interactions are studied.
What is Mirtazapine?
Mirtazapine has active ingredients of mirtazapine. It is used in depression. Currently, eHealthMe is studying from 76,046 Mirtazapine users.
What is Simbrinza?
Simbrinza has active ingredients of brimonidine tartrate; brinzolamide. It is used in glaucoma. Currently, eHealthMe is studying from 4,410 Simbrinza users.
Number of Mirtazapine and Simbrinza reports submitted per year:
Common Mirtazapine and Simbrinza drug interactions by gender *:
female:
- Blood magnesium decreased
- Cerebrovascular accident
- Fall
- Muscle spasms
- Musculoskeletal pain
- Rib fracture
- Somnolence
male:
- Aphasia
- Atrial fibrillation
- Miosis
- Pulmonary mass
- Subdural haematoma
- Suicide attempt
- Coma
- Disturbance in attention
- Dyspnoea
- Encephalopathy
Common Mirtazapine and Simbrinza drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Aphasia
- Atrial fibrillation
- Miosis
- Musculoskeletal pain
- Pulmonary mass
- Rib fracture
- Somnolence
- Subdural haematoma
- Suicide attempt
- Coma
* Approximation only. Some reports may have incomplete information.
Do you take Mirtazapine and Simbrinza?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drug side effects by duration, gender and age:
- Mirtazapine side effects (76,046 reports)
- Simbrinza side effects (4,410 reports)
Common Mirtazapine drug interactions:
- Mirtazapine and Omeprazole: 7,014 reports
- Mirtazapine and Gabapentin: 6,712 reports
- Mirtazapine and Pantoprazole: 6,323 reports
- Mirtazapine and Lorazepam: 6,200 reports
- Mirtazapine and Loraz: 5,432 reports
- Mirtazapine and Aspirin: 5,367 reports
- Mirtazapine and Sertraline: 5,356 reports
- Mirtazapine and Amlodipine: 5,105 reports
- Mirtazapine and Diazepam: 4,892 reports
- Mirtazapine and Furosemide: 4,891 reports
Browse interactions between Mirtazapine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Simbrinza drug interactions:
- Simbrinza and Travatan: 617 reports
- Simbrinza and Latanoprost: 547 reports
- Simbrinza and Lumigan: 467 reports
- Simbrinza and Travatan z: 400 reports
- Simbrinza and Timolol: 368 reports
- Simbrinza and Brimonidine: 247 reports
- Simbrinza and Aspirin: 242 reports
- Simbrinza and Azopt: 216 reports
- Simbrinza and Amlodipine: 213 reports
- Simbrinza and Vitamin d: 210 reports
Browse interactions between Simbrinza and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on mirtazapine and brimonidine tartrate; brinzolamide (the active ingredients of Mirtazapine and Simbrinza, respectively), and Mirtazapine and Simbrinza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Mirtazapine and Simbrinza.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Sutent and Tinnitus - now
- Vicodin and Mood Disorder - 4 seconds ago
- Rebetol and Altace drug interaction - 14 seconds ago
- Sulfamethoxazole and Tresiba drug interaction - 14 seconds ago
- Gabapentin and Ototoxicity - 25 seconds ago
- Doxycycline Hyclate and Januvia drug interaction - 26 seconds ago
- Zoledronic and Lipitor drug interaction - 29 seconds ago
- Kionex and Renal Failure - Acute - 30 seconds ago
- Kionex and Acute Kidney Failure - 30 seconds ago
- Miacalcin and Fludrocortisone Acetate drug interaction - 41 seconds ago